30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Timothy Gray

Track

Insider profile

Currently holds positions in Medimmune LLC and Anterix Inc

Performance

Overall performance
4.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 90% 68% 82%
Transactions
11 64% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Medimmune LLC Nov. 1, 2011 -
Chief Financial Officer Anterix Inc June 1, 2014 -
Timothy Gray's trades of NextNav Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-23 2026-03-20
S Sale
80,309 -35.5%
347.89
US$4,544,982 		80,309 -35.5% 347.89 US$4,544,982
2026-03-20 2026-03-20
PrS Proposed sale
50,797
193.18
US$4,723,236 		50,797 193.18 US$4,723,236
2025-08-21 2025-08-19
US Anterix Inc (ATEX)
B Purchase
34,173 -22.3%
406.40
US$1,140,598 		34,173 -22.3% 406.40 US$1,140,598
2024-05-03 2024-05-03
US Anterix Inc (ATEX)
PrS Proposed sale
16,666
32.26
US$537,595 		16,666 32.26 US$537,595
2024-05-03 2024-05-03
US Anterix Inc (ATEX)
PlS Planned sale
16,666 -15.6%
32.26
US$537,645 		16,666 -15.6% 32.26 US$537,645
2024-05-03 2024-05-03
US Anterix Inc (ATEX)
PlS Planned sale
16,666 -15.6%
32.26
US$537,645 		16,666 -15.6% 32.26 US$537,645
2024-05-03 2024-05-02
US Anterix Inc (ATEX)
PlS Planned sale
16,667 -15.6%
31.91
US$531,844 		16,667 -15.6% 31.91 US$531,844
2024-05-03 2024-05-02
US Anterix Inc (ATEX)
PlS Planned sale
16,667 -15.6%
31.91
US$531,844 		16,667 -15.6% 31.91 US$531,844
2024-05-02 2024-05-02
US Anterix Inc (ATEX)
PrS Proposed sale
16,667
31.91
US$531,836 		16,667 31.91 US$531,836
2024-05-03 2024-05-01
US Anterix Inc (ATEX)
PlS Planned sale
2,794 -3.0%
32.53
US$90,889 		2,794 -3.0% 32.53 US$90,889
2024-05-03 2024-05-01
US Anterix Inc (ATEX)
PlS Planned sale
2,794 -3.0%
32.53
US$90,889 		2,794 -3.0% 32.53 US$90,889
2024-05-03 2024-05-01
US Anterix Inc (ATEX)
PlS Planned sale
13,873 -12.9%
32.01
US$444,075 		13,873 -12.9% 32.01 US$444,075
2024-05-03 2024-05-01
US Anterix Inc (ATEX)
PlS Planned sale
13,873 -12.9%
32.01
US$444,075 		13,873 -12.9% 32.01 US$444,075
2024-05-01 2024-05-01
US Anterix Inc (ATEX)
PrS Proposed sale
16,667
32.10
US$534,979 		16,667 32.10 US$534,979
2023-02-27 2023-02-24
US Anterix Inc (ATEX)
B Purchase
100 +0.1%
29.04
US$2,904 		100 +0.1% 29.04 US$2,904
2022-09-19 2022-09-16
US Anterix Inc (ATEX)
B Purchase
100 +0.1%
36.67
US$3,667 		100 +0.1% 36.67 US$3,667
2022-06-01 2022-05-27
US Anterix Inc (ATEX)
B Purchase
100 +0.1%
42.64
US$4,264 		100 +0.1% 42.64 US$4,264
2021-12-21 2021-12-20
US Anterix Inc (ATEX)
B Purchase
100 +0.1%
54.94
US$5,494 		100 +0.1% 54.94 US$5,494
2021-12-06 2021-12-02
US Anterix Inc (ATEX)
B Purchase
100 +0.1%
59.64
US$5,964 		100 +0.1% 59.64 US$5,964
2021-02-22 2021-02-19
US Anterix Inc (ATEX)
B Purchase
225 +0.4%
44.57
US$10,029 		225 +0.4% 44.57 US$10,029
2020-09-02 2020-09-02
US Anterix Inc (ATEX)
S Sale
3,338 -5.4%
42.85
US$143,034 		3,338 -5.4% 42.85 US$143,034
2020-06-08 2020-06-05
US Anterix Inc (ATEX)
S Sale
2,094 -3.6%
58.18
US$121,829 		2,094 -3.6% 58.18 US$121,829
2020-06-08 2020-06-04
US Anterix Inc (ATEX)
S Sale
3,254 -5.3%
54.89
US$178,602 		3,254 -5.3% 54.89 US$178,602